Deep Singh is a biotech company builder and operational leader with over 19 years of experience advancing novel therapeutic solutions for severe neurological and pediatric diseases. As EVP, Business & Operations at Neela Therapeutics, Deep is responsible for driving strategy, operations, R&D execution, and organizational growth. Previously, Deep was a founding team member at Alcyone Therapeutics, where he helped grow the company from inception through its acquisition by Biogen. He brings deep expertise in precision CNS drug delivery and drug development, with leadership responsibility spanning R&D, operations, and corporate development.